Pediatrix Medical Group Dirección
Dirección controles de criterios 3/4
El CEO de Pediatrix Medical Group's es Jim Swift , nombrado en Jan 2023, tiene una permanencia de 1.25 años. compensación anual total es $2.24M, compuesta por 29% salario y 71% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.15% de las acciones de la empresa, por valor de $1.16M. La antigüedad media del equipo directivo y de la junta directiva es de 2.3 años y 3.8 años, respectivamente.
Información clave
Jim Swift
Chief Executive Officer (CEO)
US$2.2m
Compensación total
| Porcentaje del salario del CEO | 29.0% |
| Permanencia del CEO | 1.3yrs |
| Participación del CEO | 0.2% |
| Permanencia media de la dirección | 2.3yrs |
| Promedio de permanencia en la Junta Directiva | 3.8yrs |
Actualizaciones recientes de la dirección
Recent updates
Pediatrix Medical Group, Inc.'s (NYSE:MD) Price Is Right But Growth Is Lacking
Mar 29
Pediatrix Medical Group, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 100% Above Its Share Price
Jan 10Pediatrix Medical Group, Inc.'s (NYSE:MD) Earnings Are Not Doing Enough For Some Investors
Dec 25Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?
Nov 14Is It Time To Consider Buying Pediatrix Medical Group, Inc. (NYSE:MD)?
Oct 13Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?
Aug 09Pediatrix: Unable To Deploy Capital Tied Up In Cash Conversion Cycle, Reiterate Hold
Aug 08At US$14.21, Is Pediatrix Medical Group, Inc. (NYSE:MD) Worth Looking At Closely?
Jul 03The Returns At Pediatrix Medical Group (NYSE:MD) Aren't Growing
Jun 08Pediatrix Medical Group (NYSE:MD) Has A Somewhat Strained Balance Sheet
Apr 26Is Now An Opportune Moment To Examine Pediatrix Medical Group, Inc. (NYSE:MD)?
Feb 20Pediatrix Medical Group Q4 2022 Earnings Preview
Feb 16Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?
Jan 12Pediatrix: RCM Overhang Now Too Heavy, Revise To Hold
Dec 22Return Trends At Pediatrix Medical Group (NYSE:MD) Aren't Appealing
Dec 20Pediatrix appoints James Swift as chief executive officer
Dec 15Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching
Nov 05Pediatrix Medical Group GAAP EPS of $0.37 misses by $0.11, revenue of $489.92M misses by $21.54M
Nov 03Pediatrix: These 5 Graphs Suggest It's A Buy
Sep 29Here's Why Pediatrix Medical Group (NYSE:MD) Can Manage Its Debt Responsibly
Sep 13Here's What To Make Of Pediatrix Medical Group's (NYSE:MD) Decelerating Rates Of Return
Aug 29Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching
Jul 27Pediatrix: Seeking 46% Return Objective As Speculative Buy
Jul 14MEDNAX, Inc. (NYSE:MD) Shares Could Be 47% Below Their Intrinsic Value Estimate
Jun 24MEDNAX (NYSE:MD) Has A Pretty Healthy Balance Sheet
May 25Return Trends At MEDNAX (NYSE:MD) Aren't Appealing
Apr 20MEDNAX, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 96% Above Its Share Price
Mar 08MEDNAX (NYSE:MD) Seems To Use Debt Quite Sensibly
Feb 15Here's What's Concerning About MEDNAX's (NYSE:MD) Returns On Capital
Jan 19Is MEDNAX, Inc. (NYSE:MD) Trading At A 40% Discount?
Nov 17These 4 Measures Indicate That MEDNAX (NYSE:MD) Is Using Debt Reasonably Well
Oct 23Here's What's Concerning About MEDNAX's (NYSE:MD) Returns On Capital
Oct 08Is MEDNAX (NYSE:MD) A Risky Investment?
Jul 19MEDNAX (NYSE:MD) Could Be Struggling To Allocate Capital
Jun 27Statutory Profit Doesn't Reflect How Good MEDNAX's (NYSE:MD) Earnings Are
May 15Mednax Q1 2021 Earnings Preview
May 06Does MEDNAX (NYSE:MD) Have A Healthy Balance Sheet?
Mar 14Returns On Capital At MEDNAX (NYSE:MD) Paint An Interesting Picture
Feb 15
Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | US$2m | US$650k | -US$60m |
| Sep 30 2023 | n/a | n/a | US$88m |
| Jun 30 2023 | n/a | n/a | US$95m |
| Mar 31 2023 | n/a | n/a | US$98m |
| Dec 31 2022 | US$1m | US$450k | US$63m |
Compensación vs. Mercado: La compensación total de Jim($USD2.24M) está por debajo de la media de empresas de tamaño similar en el mercado US ($USD3.44M).
Compensación vs. Ingresos: La compensación de Jim ha aumentado mientras la empresa no es rentable.
CEO
Jim Swift (60 yo)
1.3yrs
Permanencia
US$2,237,839
Compensación
Dr. James D. Swift, M.D., also known as Jim, is Director of Brave Care, Inc. since October 2021. He had been the Chief Operating Officer at Pediatrix Medical Group, Inc. since May 2022 until December 31, 2...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Director | 1.3yrs | US$2.24m | 0.15% $ 1.1m | |
| Executive VP & CFO | 3.7yrs | US$1.78m | 0.21% $ 1.6m | |
| Executive VP & COO | 1.3yrs | US$1.88m | 0.088% $ 666.4k | |
| Executive VP | 1.6yrs | US$1.83m | 0.15% $ 1.1m | |
| Executive Vice President of National & Market Operations | no data | US$1.39m | 0.11% $ 830.5k | |
| Senior VP & Chief Accounting Officer | 8yrs | US$1.43m | sin datos | |
| Senior VP & Chief Information Officer | 2.3yrs | sin datos | sin datos | |
| Senior Vice President of Administration & Managed Care | no data | sin datos | sin datos | |
| Senior VP of Finance | no data | sin datos | sin datos | |
| Senior VP | 2.8yrs | sin datos | sin datos | |
| President of Regional Operations (Central) | no data | sin datos | sin datos | |
| President of Regional Operations (South-Central) | no data | sin datos | sin datos |
2.3yrs
Permanencia media
60yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de MD se considera experimentado (2.3 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Director | 1.2yrs | US$2.24m | 0.15% $ 1.1m | |
| Chair | 3.8yrs | US$554.45k | 0.18% $ 1.3m | |
| Lead Independent Director | 3.8yrs | US$295.00k | 0.060% $ 455.7k | |
| Independent Director | 3.8yrs | US$252.50k | 0.044% $ 330.9k | |
| Independent Director | less than a year | US$201.00k | 0.013% $ 98.8k | |
| Independent Director | 3.8yrs | US$230.00k | 0.044% $ 330.8k | |
| Independent Director | 3.8yrs | US$245.00k | 0.021% $ 161.1k | |
| Board Observer | 3.8yrs | sin datos | sin datos | |
| Independent Director | 5yrs | US$242.50k | 0.048% $ 362.9k | |
| Independent Director | 2yrs | US$230.00k | 0.024% $ 177.3k |
3.8yrs
Permanencia media
59.5yo
Promedio de edad
Junta con experiencia: La junta directiva de MD se considera experimentada (3.8 años de antigüedad promedio).